Alfuzosine (standaard)

Alfuzosin (Standard) is the analytical standard of Alfuzosin. This product is intended for research and analytical applications. Alfuzosin (SL 77499-10) is an orally active, selective and competitive α1-adrenoceptor antagonist. Alfuzosin relaxes the muscles of the prostate and bladder neck, aiding in urination. Alfuzosin can be used in study of benign prostatic hyperplasia (BPH) [1][2].

81403-80-7

SL 77499 (Standard)

12352100

Adrenergic Receptor; Reference Standards

GPCR/G Protein; Neuronal Signaling; Others

Endocrinology

O=C(C1OCCC1)NCCCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)C

C19H27N5O4

389.45

[1]Martin DJ, et al. Relationship between the effects of alfuzosin on rat urethral and blood pressures and its tissue concentrations. Life Sci. 1998;63 (3) :169-76. |[2]Wilde MI, et al. Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia. Drugs. 1993 Mar;45 (3) :410-29.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-B0192R/

Reference Standards

Launched